Raymond Dwek

Director/Board Member at UNITED THERAPEUTICS CORPORATION

Net worth: 412 913 $ as of 2024-04-29

82 year

100 connections

Health Technology

Consumer Services

Government

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Raj Bhikhu Parekh	M	63	Oxford GlycoSciences Plc Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK.	15 years
Robert Holmes	M	-	University of Oxford	8 years
Adam Brunet	M	-	University of Oxford	10 years
Alan Colman	M	75	University of Oxford	8 years
Jason Evans	M	-	University of Oxford	9 years
John Thornton	M	70	University of Oxford	4 years
Doron Junger	M	-	University of Oxford	6 years
Bader Abdulmohsen Nassir El-Jeaan	M	-	University of Oxford	6 years
Yannis Stournaras	M	67	University of Oxford	3 years
Philip Hodges	M	-	University of Oxford	7 years
David John Rawlins	M	43	University of Oxford	3 years
Houman Ashrafian	M	49	University of Oxford	8 years
Peter A. Chew	M	-	University of Oxford	5 years
Michael David Hamer	M	-	University of Oxford	5 years
Akhil Paul	M	39	University of Oxford	4 years
Davide Giacomo Federico Benello	M	70	University of Oxford	4 years
Heng Heng Goh	M	-	University of Oxford	6 years
Danaraj Nadarajah	M	70	University of Oxford	4 years
Ka Shuen Wen	M	70	University of Oxford	8 years
Siddharth T. Patel	M	46	University of Oxford	6 years
Julian Graeme Ross	M	59	University of Oxford	6 years
Gao Meng	F	43	University of Oxford	5 years
Robin N. Lowe	M	59	University of Oxford	4 years
Catherine Fraser	F	-	University of Oxford	4 years
Hong Jun Zhong	M	53	University of Oxford	3 years
Simon Wolfgang Hartmut Goeller	M	44	University of Oxford	5 years
Peter Bilitsch	M	49	University of Oxford	6 years
Michael Hewett	M	-	University of Oxford	7 years
Argyris Stasinakis	M	-	University of Oxford	8 years
Richard Kirby Taylor	M	64	University of Oxford	6 years
Rupert Charles de Borchgrave d'Altena	M	-	University of Oxford	7 years
Rabeel Warraich	M	-	University of Oxford	4 years
Matt Greenwood	M	-	University of Oxford	3 years
Nigel L. Clarke	M	-	University of Oxford	4 years
Julia Black	F	-	University of Oxford	8 years
Matthew le Merle	M	-	University of Oxford	3 years
Tak Chi Woo Chan	F	48	University of Oxford	6 years
Inga Deakin	M	-	University of Oxford	5 years
Ross Frederick Cranston	M	75	University of Oxford	7 years
David Zaccardelli	M	59	UNITED THERAPEUTICS CORPORATION	12 years
Kathryn Farrar	F	47	University of Oxford	5 years
Taksz Ildiko	M	55	University of Oxford	5 years
Girindre Beeharry	M	-	University of Oxford	2 years
Tai Lok Lui	M	66	University of Oxford	5 years
Ick-Soo Kim	M	68	University of Oxford	3 years
Michael Robert Evans	M	66	University of Oxford	7 years
Craig D. Jones	M	-	University of Oxford	6 years
Andrew N. Rowan	M	-	University of Oxford	4 years
William Ashby	M	-	University of Oxford	4 years
Antony J. Fairbanks	M	-	University of Oxford	3 years
Margaret A. Wheatley	M	-	University of Oxford	7 years
W. Edward Alastair Morrison	M	66	University of Oxford	6 years
Stephen Swaffield	M	61	University of Oxford	6 years
Daniel Kapi	M	-	University of Oxford	5 years
Peter Jones	M	67	University of Oxford	3 years
William Guilherme Doo	M	51	University of Oxford	6 years
Jai Swaroop Pathak	M	65	University of Oxford	6 years
Peter W. Strivens	M	-	University of Oxford	6 years
Harry Small	M	-	University of Oxford	6 years
Reid Hoffman	M	56	University of Oxford	8 years
Dale Pfost	M	-	Oxford GlycoSciences Plc Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK.	8 years
Gregg Robins	M	-	University of Oxford	7 years
Chad Frischmann	M	-	University of Oxford	5 years
Christa Ehmann Powers	M	-	University of Oxford	5 years
Emre Yigit	M	-	University of Oxford	6 years
Yat Hung Fu	M	60	University of Oxford	6 years
Douglas S. Eakeley	M	-	University of Oxford	1 years
Rachel Webster	M	-	University of Oxford	5 years
Rayhan Davis	M	45	University of Oxford	4 years
Randall MacKey	M	77	University of Oxford	3 years
Doug Bewsher	M	55	University of Oxford	1 years
Gordon Orr	M	63	University of Oxford	4 years
Tim Parker	M	68	University of Oxford	4 years
Robert Moore	M	-	University of Oxford	1 years
Andy Quak Ser-Khoon	M	-	University of Oxford	4 years
Mark Brooker	M	52	University of Oxford	4 years
Charles Joseph Moore	M	-	University of Oxford	2 years
Nick Rose	M	67	University of Oxford	1 years
Natalia Gurushina	M	-	University of Oxford	5 years
Masha Paule Nathalie Strømme	M	53	University of Oxford	4 years
Neill Penney	M	-	University of Oxford	4 years
Peter Mikkelsen	M	71	University of Oxford	4 years
Yau Hool	M	-	University of Oxford	4 years
Jeffrey Moore	M	-	University of Oxford	4 years
David C. Parkes	M	-	University of Oxford	1 years
Sacha Taylor	F	-	University of Oxford	1 years
Beng Ee Fung	M	62	University of Oxford	1 years
Simon William Moore	M	46	University of Oxford	10 years
Christopher Robert Eskdale	M	54	University of Oxford	1 years
Kevin L. Thurm	M	62	University of Oxford	1 years
Benjamin R. Little	M	-	University of Oxford	1 years
Caroline L. Hickson	F	-	University of Oxford	4 years
Robert Boisture	M	-	University of Oxford	4 years
Steven Beach	M	-	University of Oxford	3 years
Tim Spence	M	-	University of Oxford	3 years
Matthew James Whittell	M	-	University of Oxford	4 years
David Charles Hawkins	M	58	University of Oxford	1 years
Thomas Robinson	M	-	University of Oxford	1 years
Delon Dotson	M	-	University of Oxford	2 years
David Hawkes	M	71	University of Oxford	4 years

Statistics

Country	Connections	% of total
United Kingdom	99	99.00%
United States	1	1.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections